Click (CLIK) Stock Price, News & Analysis

Company Overview

Click Therapeutics, Inc. (NASDAQ: CLIK) is a digital therapeutics company focused on the development and commercialization of prescription software-based treatments for mental health and other chronic conditions. The company’s proprietary platform delivers evidence-based interventions—such as cognitive behavioral therapy, mindfulness training and behavior-change techniques—through mobile applications and web portals. Its core pipeline includes programs targeting major depressive disorder, insomnia and nicotine dependence, all designed to support patients and clinicians with remote monitoring, personalized content and real-time engagement analytics.

Founded in 2013 by Michael J. Nusbaum and a team of clinicians and technologists, Click is headquartered in New York City with additional operations across North America and Europe. The company partners with biopharmaceutical firms, healthcare providers and payers to integrate its digital therapeutics into clinical care pathways and reimbursement frameworks. Click’s development strategy is underpinned by randomized controlled trials and ongoing regulatory dialogues, including engagement with the U.S. Food and Drug Administration to secure prescription status for its software programs.

Under the leadership of CEO Michael A. Nusbaum, Click’s executive team combines expertise in psychiatry, digital health, regulatory affairs and data science. The company continues to expand its global footprint through strategic research collaborations, commercialization agreements and alliances aimed at providing scalable, personalized digital treatment solutions. By leveraging real-world evidence and outcome-driven analytics, Click Therapeutics seeks to transform the delivery of care for patients, providers and payers worldwide.

Key Stats

• Today's Range: $0.35 to $0.37
• 50-Day Range: $0.24 to $0.71
• 52-Week Range: $0.16 to $4.39
• Volume: 1.05 million shs
• Average Volume: 4.12 million shs
• Market Capitalization: $11.72 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CLIK Stock Analysis - Frequently Asked Questions

How have CLIK shares performed this year?

Click's stock was trading at $1.19 at the beginning of 2025. Since then, CLIK stock has decreased by 68.9% and is now trading at $0.3699.

When did Click IPO?

Click (CLIK) raised $6 million in an initial public offering on Wednesday, October 9th 2024. The company issued 1,500,000 shares at a price of $4.00 per share. R.F. Lafferty & Co. and Revere Securities acted as the underwriters for the IPO.

How do I buy shares of Click?

Shares of CLIK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 7/16/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Business Services
• Industry: BUSINESS INFO SVC
• Sub-Industry: Business Services
• Current Symbol: NASDAQ:CLIK
• CIK: 2020027
• Web: N/A
• Phone: 852 3758 2780
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 4.50
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $5.66 million
• Price / Sales: 2.07
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.35 per share
• Price / Book: 1.06

Miscellaneous

• Outstanding Shares: 31,680,000
• Free Float: N/A
• Market Cap: $11.72 million
• Optionable: N/A
• Beta: N/A